Video

What Are the Challenges Associated with Centralized Compounding Parenteral Nutrition?

Conference|ASHP Midyear Clinical Meeting and Exhibition - American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition

Mark Barricklow, RPh, discusses the challenges associated with centralized compounding parenteral nutrition.

Mark Barricklow, RPh, discusses the challenges associated with centralized compounding parenteral nutrition.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Gang | stock.adobe.com
Related Content
Shingles (Herpes Zoster) Vaccination title topic vaccination | Image Credit: daniiiD | stock.adobe.com
August 23rd 2025

Shingles Vaccine Linked to Reduced Risks of Stroke, Myocardial Infarction, and Herpes Zoster Ophthalmicus

Danielle Valletti, Assistant Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 23rd 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Amish children with adult walking | Image Credit: © MMerellinn - stock.adobe.com
August 23rd 2025

The Farm Effect: What Amish Communities Can Teach Us About Allergy Prevention

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
August 23rd 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Vibrant Green Mitragyna Speciosa Plantation Leaves | Image Credit: Yonus | stock.adobe.com
August 23rd 2025

Natural Alkaloids From Mitragyna speciosa Show Potential as Novel HER2 Inhibitors in Breast Cancer

Danielle Valletti, Assistant Editor
Ambulatory chemotherapy | Image Credit: RFBSIP | stock.adobe.com
August 23rd 2025

Limited Benefit of Adjuvant Chemotherapy in Older Women With HR-Positive, HER2-Negative Breast Cancer

Danielle Valletti, Assistant Editor